Study Stopped
Organizational problems, change of research priorities
tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury
Observational Study on the Use of Transcranial Direct Stimulation in Patients With Disorder of Consciousness, Due to Severe Acquired Brain Injury, to Stimulate Recovery of Consciousness
1 other identifier
observational
1
1 country
1
Brief Summary
The present observational study is aimed at reporting the short-, mid- and long-term outcomes of patients with Disorder of Consciousness (DOC), in Vegetative State (VS) or Minimally Conscious State (MCS), due to a severe Acquired Brain Injury (sABI), after repeated treatments with anodal Transcranial Direct Current Stimulation (tDCS) on Left Dorsolateral Prefrontal Cortex (L-DLPFC), to stimulate recovery of consciousness. The results obtained will also be compared with those of a historical control cohort, before the introduction of tDCS, matched for demographic and clinical characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2017
CompletedFirst Posted
Study publicly available on registry
December 8, 2017
CompletedStudy Start
First participant enrolled
June 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 14, 2020
August 1, 2020
2 years
December 4, 2017
August 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in coma recovery in the tDCS cohort (short- and mid-term outcomes)
Assessment by Coma Recovery Scale-Revised (CRS-R) (on-line, where tDCS is administered)
Baseline (initial visit); tDCS session 5 (1 week); tDCS closing session 10 (2 weeks); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10)
Change in cognitive functioning level in the tDCS cohort (short- and mid-term outcomes)
Assessment by Levels of Cognitive Functioning Scale (LCF) (off-line, i.e. where tDCS is administered, immediately after tDCS session)
Baseline (initial visit); tDCS session 5 (1 week); tDCS closing session 10 (2 weeks); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10)
Secondary Outcomes (7)
Change in coma recovery in the tDCS cohort (long-term outcome)
Baseline (initial visit); follow-up 3 (6 months after tDCS closing session 10)
Change in cognitive functioning level in the tDCS cohort (long-term outcome)
Baseline (initial visit); follow-up 3 (6 months after tDCS closing session 10)
Change in disability level in the tDCS cohort (short-, mid- and long-term follow-up)
Baseline (initial visit); follow-up 1 (1 week after tDCS closing session 10); follow-up 2 (3 months after tDCS closing session 10); follow-up 3 (6 months after closing session 10)
Change in electroencephalography pattern in the tDCS cohort
Baseline (initial visit); tDCS tDCS closing session 10 (2 weeks)
Change in coma recovery between the tDCS cohort and the Historical control cohort
Baseline (initial visit); 3 months; 6 months
- +2 more secondary outcomes
Study Arms (2)
tDCS cohort
DOC patients treated according to usual care, plus anodal tDCS (prospective cohort)
Historical control cohort
DOC patients treated according to usual care only (retrospective cohort of patients matched for demographic and clinical characteristics, admitted at the Montecatone Rehabilitation Institute no more than 3 years before the introduction of tDCS)
Interventions
Anodal tDCS, on L-DLPFC area, is started 2 weeks after admission to the sABI Operative Unit with: one session per day (in the morning), possibly for 5 consecutive days per week (from Monday to Friday), for 2 consecutive weeks. Each tDCS session lasts 20 minutes. Current intensity is 1 mA during the first week, 2 mA in the second week
Eligibility Criteria
Consecutive DOC patients admitted to the sABI Operative Unit of the Montecatone Rehabilitation Institute
You may qualify if:
- patients with Disorder of Consciousness, VS (= LCF 2) or MCS (= LCF 3), due to sABI;
- any etiology, with the exception of extensive haemorrhagic lesions;
- stable clinical conditions.
You may not qualify if:
- presence of implanted devices (e.g. pacemakers, intrathecal infusers);
- presence of metallic brain implants (clips) or intracranial implants;
- presence of extensive craniotomy involving the area of application of tDCS;
- history of epileptic seizure;
- mechanical ventilation in place;
- history of psychotic disorders;
- severe neurodegenerative pathology;
- pharmacotherapy with Na+ or Ca++ channel blockers (e.g. Carbamazepine) or with N-Methyl-D-aspartate (NMDA) receptor antagonists (e.g. Dextromethorphan);
- pregnancy in progress.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montecatone Rehabilitation Institute S.p.A.
Imola, BO, 40026, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Morreale, MD
Montecatone Rehabilitation Institute S.p.A.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2017
First Posted
December 8, 2017
Study Start
June 18, 2018
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
August 14, 2020
Record last verified: 2020-08